|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Recombinant Human IL18R1 protein (Catalog#11102-H08H)|
|0.2 μm filtered solution in PBS with 5% trehalose|
|This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human IL18R1 / CD218a (rh IL18R1; Catalog#11102-H08H; NP_003846.1; Met 1-Arg 329). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.|
|Human IL18R1 / CD218a
No cross-reactivity in ELISA with
Human IL1R1 / CD121a
Human IL1R2 / CD121b
Human IL1R3 / IL1RAP
Human IL1RL1 / IL1R4 / ST2
Human IL18RAP / IL1R7
Human IL1RAPL1 / IL1R8
Human IL1R9 / IL1RAPL2
Mouse IL18R1 / CD218a
Mouse TIR8 / SIGIRR
Human cell lysate (293 cell line)
ELISA: 0.5-1 μg/mL
This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human IL18R1. The detection limit for Human IL18R1 is 0.039 ng/well.
|This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.|
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Interleukin-18 receptor 1 (IL18R1) also known as CD218 antigen-like family member A, CDw218a, IL1 receptor-related protein and CD218a, is an interleukin receptor of the immunoglobulin superfamily. IL18R1 is found expressed in lung, leukocytes, spleen, liver, thymus, prostate, small intestine, colon, placenta, and heart, and is absent from brain, skeletal muscle, pancreas, and kidney. High level of expression is found in Hodgkin disease cell lines. This receptor is specifically binds interleukin 18 (IL18), and is essential for IL18 mediated signal transduction. IL18R1 contains 3 Ig-like C2-type (immunoglobulin-like) domains and 1 TIR domain. It is a single-pass type I membrane protein. IFN-alpha and IL12 are reported to induce the expression of this receptor in NK and T cells. The increased expression of IL18R1 may contribute pathogenically to disease and is therefore a potential therapeutic target. The absence of a genetic association in the IL18R1 gene itself suggests regulation from other parts of the genome, or as part of the inflammatory cascade in multiple sclerosis without a prime genetic cause.